Trimethoprim-induced hyperkalemia in renal transplant recipient
Trimethoprim-sulfamethoxazole (TMP-SMX) is an antimicrobial agent used in a variety of infections. Adverse reactions are more common in patients with AIDS but occasionally occur in immunocompetent patients. Renal toxicity is usually a hypersensitivity reaction to the sulfa component and manifests as interstitial nephritis or sulfa crystallization in the renal tubules. Reversible hyperkalemia is a rarely reported side effect of TMP-SMX therapy attributed to TMP inhibition of potassium secretion in the distal renal tubule in a manner similar to the potassium-sparing diuretic, amiloride. We report a case of hyperkalemia associated with TMP-SMX occurring in a 32-year-old renal transplant recipient with no other risk factors for hyperkalemia. He was treated with TMP-SMX (800 mg + 160 mg) two tablets QID for suspected pneumocystis jiroveci pneumonia. He developed severe hyperkalemia on day 9 posttherapy. Hyperkalemia reverted to normal with withdrawal of trimethoprim..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Indian Journal of Transplantation - 12(2018), 2, Seite 149-151 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Abhijeet S More [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Hyperkalemia |
---|
doi: |
10.4103/ijot.ijot_4_18 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ020995628 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ020995628 | ||
003 | DE-627 | ||
005 | 20230307042706.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4103/ijot.ijot_4_18 |2 doi | |
035 | |a (DE-627)DOAJ020995628 | ||
035 | |a (DE-599)DOAJef0536e979324cd2be96ab8d63f2a29f | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RD1-811 | |
100 | 0 | |a Abhijeet S More |e verfasserin |4 aut | |
245 | 1 | 0 | |a Trimethoprim-induced hyperkalemia in renal transplant recipient |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Trimethoprim-sulfamethoxazole (TMP-SMX) is an antimicrobial agent used in a variety of infections. Adverse reactions are more common in patients with AIDS but occasionally occur in immunocompetent patients. Renal toxicity is usually a hypersensitivity reaction to the sulfa component and manifests as interstitial nephritis or sulfa crystallization in the renal tubules. Reversible hyperkalemia is a rarely reported side effect of TMP-SMX therapy attributed to TMP inhibition of potassium secretion in the distal renal tubule in a manner similar to the potassium-sparing diuretic, amiloride. We report a case of hyperkalemia associated with TMP-SMX occurring in a 32-year-old renal transplant recipient with no other risk factors for hyperkalemia. He was treated with TMP-SMX (800 mg + 160 mg) two tablets QID for suspected pneumocystis jiroveci pneumonia. He developed severe hyperkalemia on day 9 posttherapy. Hyperkalemia reverted to normal with withdrawal of trimethoprim. | ||
650 | 4 | |a Hyperkalemia | |
650 | 4 | |a kidney transplant | |
650 | 4 | |a pneumocystis jiroveci pneumonia | |
650 | 4 | |a trimethoprim | |
653 | 0 | |a Surgery | |
700 | 0 | |a Nilesh R Bhange |e verfasserin |4 aut | |
700 | 0 | |a Kshitija G Gadekar |e verfasserin |4 aut | |
700 | 0 | |a Sudhir G Kulkarni |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Indian Journal of Transplantation |d Wolters Kluwer Medknow Publications, 2019 |g 12(2018), 2, Seite 149-151 |w (DE-627)DOAJ000031232 |x 22120025 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2018 |g number:2 |g pages:149-151 |
856 | 4 | 0 | |u https://doi.org/10.4103/ijot.ijot_4_18 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/ef0536e979324cd2be96ab8d63f2a29f |z kostenfrei |
856 | 4 | 0 | |u http://www.ijtonline.in/article.asp?issn=2212-0017;year=2018;volume=12;issue=2;spage=149;epage=151;aulast=More |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2212-0017 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2212-0025 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 12 |j 2018 |e 2 |h 149-151 |